Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04693663 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile

Study acronym: Relex-Smile
StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion pushed from Jun 1, 2026 to Jun 1, 2027v6
  2. Study completion date: Jun 1, 2024 to Jun 1, 2026v5
  3. Re-verified, no change to tracked fieldsv4
  4. Study completion date: Jun 1, 2022 to Jun 1, 2024v3
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to assess visual and refractive outcomes after laser vision correction (LVC) - ReLex Smile to correct residual myopic refraction after 6 months of pseudophakic (IOL) implantation. Before SMILE YAG-Laser capsulotomy should be performed on all patients, regardless of posterior capsule ossification, in pseudophakic patients with residual refraction. When the YAG Laser is applied after the SMILE, there will be a diopter change.
Trial Details
NCT Number NCT04693663
Lead Sponsor Eye Hospital Pristina Kosovo
Conditions
(from sponsor)		 Pseudophakia, Myopia
Related terms Myopia, Pseudophakia
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov